Q2 2021 Holdings
Filed 2021-08-16 | 87 holdings | $1.5B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kadmon Hldgs Inc(KDMN)A | COM | 48283N106 | $3.5M | 894,995 | 0.2% |
| Merck & Co Inc(MRK)CallA | COM | 58933Y105 | $3.8M | 48,700 | 0.3% |
| Anthem Inc(ELV)A | COM | 036752103 | $3.9M | 10,132 | 0.3% |
| Dexcom Inc(DXCM)A | COM | 252131107 | $4.1M | 9,525 | 0.3% |
| Cullinan Oncology Inc(CGEM)A | COM | 230031106 | $4.2M | 163,880 | 0.3% |
| Glaxosmithkline PLCA | SPONSORED ADR | 37733W105 | $4.6M | 112,679 | 0.3% |
| Intra-Cellular Therapies Inc(ITCIEUR)A | COM | 46116X101 | $4.8M | 117,462 | 0.3% |
| Affimed N VA | COM | N01045108 | $4.8M | 566,942 | 0.3% |
| Surgalign Holdings IncA | COM | 86882C105 | $4.9M | 3,882,096 | 0.3% |
| Centene Corp del(CNC)A | COM | 15135B101 | $5.0M | 68,000 | 0.3% |
| Outset MED Inc(OMGBP)A | COM | 690145107 | $5.4M | 107,300 | 0.4% |
| Option Care Health Inc(OPCH)A | COM NEW | 68404L201 | $6.3M | 289,297 | 0.4% |
| Horizon Therapeutics PUB LCallA | SHS | G46188101 | $6.6M | 70,000 | 0.4% |
| Teladoc Health Inc(TDOC)CallA | COM | 87918A105 | $6.7M | 40,000 | 0.4% |
| Humana Inc(HUM)A | COM | 444859102 | $8.3M | 18,656 | 0.6% |
| Zogenix IncA | COM NEW | 98978L204 | $8.6M | 495,860 | 0.6% |
| Alnylam Pharmaceuticals Inc(ALNY)A | COM | 02043Q107 | $8.7M | 51,136 | 0.6% |
| Ishares TR(TIP)PutA | TIPS BD ETF | 464287176 | $9.0M | 70,000 | 0.6% |
| Magellan Health IncA | COM NEW | 559079207 | $9.9M | 104,700 | 0.7% |
| Cigna Corp New(CI)A | COM | 125523100 | $9.9M | 41,745 | 0.7% |
| Vertex Pharmaceuticals Inc(VRTX)A | COM | 92532F100 | $11.0M | 54,500 | 0.7% |
| ARK ETF TR(ARKK)A | INNOVATION ETF | 00214Q104 | $11.1M | 85,000 | 0.7% |
| Taro Pharmaceutical Inds LTDA | SHS | M8737E108 | $12.5M | 174,249 | 0.8% |
| Spdr SER TR(XBI)PutA | S&P BIOTECH | 78464A870 | $13.5M | 100,000 | 0.9% |
| Mckesson Corp(MCK)A | COM | 58155Q103 | $14.4M | 75,000 | 1.0% |
| Omnicell COM(OMCL)A | COM | 68213N109 | $14.9M | 98,366 | 1.0% |
| AMN Healthcare Svcs Inc(AMN)A | COM | 001744101 | $15.4M | 159,101 | 1.0% |
| Healthequity Inc(HQY)A | COM | 42226A107 | $15.9M | 197,500 | 1.1% |
| R1 RCM IncA | COM | 749397105 | $17.1M | 770,000 | 1.1% |
| Ionis Pharmaceuticals Inc(IONS)A | COM | 462222100 | $17.6M | 442,000 | 1.2% |
| ARK ETF TR(ARKG)CallA | GENOMIC REV ETF | 00214Q302 | $18.4M | 199,000 | 1.2% |
| Organon & Co(OGN)A | COMMON STOCK | 68622V106 | $21.2M | 699,696 | 1.4% |
| Spdr SER TR(XBI)CallA | S&P BIOTECH | 78464A870 | $27.1M | 200,000 | 1.8% |
| Envista Holdings Corporation(NVST)A | COM | 29415F104 | $28.3M | 656,098 | 1.9% |
| Amneal Pharmaceuticals Inc(AMRX)A | COM STK CL A | 03168L105 | $28.8M | 5,624,725 | 1.9% |
| Ortho Clinical Diagnostics HA | ORD SHS | G6829J107 | $29.9M | 1,394,284 | 2.0% |
| Fate Therapeutics Inc(FATE)A | COM | 31189P102 | $30.1M | 346,347 | 2.0% |
| Qiagen NV(QGEN)A | SHS NEW | N72482123 | $31.5M | 651,035 | 2.1% |
| Ascendis Pharma A/S(ASND)A | SPONSORED ADR | 04351P101 | $31.8M | 241,774 | 2.1% |
| Bristol-Myers Squibb Co(BMY)A | COM | 110122108 | $32.0M | 478,328 | 2.1% |
| Avantor Inc(AVTR)A | COM | 05352A100 | $34.6M | 974,637 | 2.3% |
| Vertex Pharmaceuticals Inc(VRTX)CallA | COM | 92532F100 | $34.9M | 173,300 | 2.3% |
| Teva Pharmaceutical Inds LTD(TEVA)A | SPONSORED ADS | 881624209 | $37.7M | 3,804,405 | 2.5% |
| Biogen Inc(BIIB)CallA | COM | 09062X103 | $40.0M | 115,600 | 2.7% |
| Acceleron Pharma Inc(XLRN)A | COM | 00434H108 | $42.0M | 335,045 | 2.8% |
| Danaher Corporation(DHR)A | COM | 235851102 | $55.0M | 204,705 | 3.7% |
| Glaxosmithkline PLCCallA | SPONSORED ADR | 37733W105 | $55.9M | 1,403,700 | 3.7% |
| Community Health SYS Inc New(CYH)A | COM | 203668108 | $59.0M | 3,821,729 | 3.9% |
| Astrazeneca PLC(AZN)A | SPONSORED ADR | 046353108 | $59.0M | 985,722 | 3.9% |
| Horizon Therapeutics PUB LA | SHS | G46188101 | $62.4M | 666,738 | 4.2% |